Home   »   About Us   »   Joseph Araujo, PhD

Our people

Joseph Araujo, PhD

CEO and President, InterVivo Solutions

Dr. Joseph Araujo is President and CEO of InterVivo Solutions, which is focused on optimizing translational services to facilitate the development and approval of novel CNS drugs.  His scientific background includes graduate training in pharmacology at the University of Toronto, more than 35 refereed publications and several invited presentations, which focus on natural aged canine models of human disease. Joseph has co-founded, held executive level positions and consulted for Life Science companies including CanCog Technologies, Vivocore, Karyopharm Therapeutics, NPM Pharma, Ketogen, and Epione Animal Health.

  • Michael Fossel, MD, PhD

    Founder, President

  • Peter Rayson

    Founder, Chief Executive Officer

  • Mark Hodges

    Chief Operating Officer (COO)

  • Russell Swerdlow, MD

    Director of Alzheimer's Diease Center. Professor of Neurology, University of Kansas

  • Brian Kaspar, PhD

    Center for Gene Therapy, Nationwide Children's Hospital Ohio

  • Suzanne Hendrix, PhD

    President, Pentara Corporation Salt Lake City, Utah

  • Mimoun Azzouz, PhD

    Chair Translational Neuroscience University of Sheffield, UK

  • Zaven Khachaturian, PhD

    Editor-in-Chief, Alzheimer’s & Dementia President PAD2020